IUS Publications

Found 28 results
Filters: Author is Sabina Semiz  [Clear All Filters]
2019
P. C. Aka, Genetic Counseling and Preventive Medicine in Bosnia and Herzegovina, in Center for Human Rights and Transitional Justice, Faculty of Law, IUS, 2019.
S. Semiz, Precision Medicine in the Era of CRISPR-Cas9: Evidence from Bosnia and Herzegovina, Palgrave Communications, 2019.
2016
C. F.H., Semiz, S., J., G., A., D., A., H., and Beyazit, Y., BH education without borders: "Knowledge is donorable and sharable",, Days of the Bosnian-Herzegovinian American Academy of Arts and Sciences (BHAAAS) in B&H, Neum, BH, . 2016.
S. Semiz, The Bosnia and Herzegovina Unit of the UNESCO Chair in Bioethics, Bioethical Voices, vol. 2 (5), 2016.
J. Liu, Semiz, S., van der Lee, S., van der Spek, A., van Dijk, K. W., Demirkan, A., and van Duijn, C. M., Metabolomics Prediction of Future Type 2 Diabetes, , 40th Anniversary of the Dutch Epidemiology Conference, Wageningen, Netherland. 2016.
T. Dujic, Čaušević, A., Bego, T., Malenica, M., Velija-Asimi, Z., Pearson, E. R., and Semiz, S., Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes., Diabet Med, vol. 33, no. 4, pp. 511-4, 2016.
S. Semiz, Personalized Therapy of Type 2 Diabetes. Sarajevo: International University of Sarajevo, 2016.
S. Semiz, Dujic, T., Velija-Asimi, Z., and Čaušević, A., Pharmacogenomics of membrane transporters and metformin response in Type 2 diabetic patients, European Journal of Human Genetics. 2016.
S. Semiz, Type 2 Diabetes: From Genes to Prognosis and Therapy. Sarajevo: International University of Sarajevo, 2016.
M. Malenica, Prnjavorac, B., Čaušević, A., Dujić, T., Bego, T., and Semiz, S., Use of Databases for Early Recognition of Risk of Diabetic Complication by Analysis of Liver Enzymes in Type 2 Diabetes Mellitus., Acta Inform Med, vol. 24, no. 2, pp. 90-3, 2016.
K. Zhou, Yee, S. Wah, Seiser, E. L., van Leeuwen, N., Tavendale, R., Bennett, A. J., Groves, C. J., Coleman, R. L., van der Heijden, A. A., Beulens, J. W., de Keyser, C. E., Zaharenko, L., Rotroff, D. M., Out, M., Jablonski, K. A., Chen, L., Javorský, M., Židzik, J., Levin, A. M., L Williams, K., Dujić, T., Semiz, S., Kubo, M., Chien, H. - C., Maeda, S., Witte, J. S., Wu, L., Tkáč, I., Kooy, A., van Schaik, R. H. N., Stehouwer, C. D. A., Logie, L., Sutherland, C., Klovins, J., Pirags, V., Hofman, A., Stricker, B. H., Motsinger-Reif, A. A., Wagner, M. J., Innocenti, F., Hart, L. M. 't, Holman, R. R., McCarthy, M. I., Hedderson, M. M., Palmer, C. N. A., Florez, J. C., Giacomini, K. M., and Pearson, E. R., Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin., Nat Genet, vol. 48, no. 9, pp. 1055-9, 2016.
2015
M. Malenica, Bego, T., Dujic, T., Prnjavorac, B., Mandal, S., and Semiz, S., THE ASSOCIATION BETWEEN COMMONLY USED INFLAMMATORY MARKERS AND URIC ACID IN PREDIABETES, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
A. Čaušević, Malenica, M., Bego, T., Dujic, T., Prnjavorac, B., Mandal, S., and Semiz, S., THE ASSOCIATION BETWEEN COMMONLY USED INFLAMMATORY MARKERS AND URIC ACID IN PREDIABETES, in Clinical Chemistry and Laboratory Medicine, 53, S1, S605, 2015.
T. Bego, Dujić, T., Mlinar, B., Semiz, S., Malenica, M., Prnjavorac, B., Ostanek, B., Marc, J., Čaušević-Ramoševac, A., and Čaušević, A., Association of LPIN1 gene variations with markers of metabolic syndrome in population from Bosnia and Herzegovina., Med Glas (Zenica), vol. 12, no. 2, pp. 113-21, 2015.
S. Semiz, Bego, T., Sterner, M., Dujic, T., Velija-Asimi, Z., Prnjavorac, B., Malenica, M., Groop, L., and Čaušević, A., ASSOCIATIONS OF SOLUTE CARRIER TRANSPORTERS GENE VARIATIONS WITH MARKERS OF TYPE 2 DIABETES AND ITS COMPLICATIONS – GENDER SPECIFIC?, in Clinical Chemistry and Laboratory Medicine, 53, S1, S650, 2015.
S. Semiz, Bego, T., Sterner, M., Dujic, T., Velija-Asimi, Z., Prnjavorac, B., Malenica, M., Groop, L., and Čaušević, A., ASSOCIATIONS OF SOLUTE CARRIER TRANSPORTERS GENE VARIATIONS WITH MARKERS OF TYPE 2 DIABETES AND ITS COMPLICATIONS – GENDER SPECIFIC?, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
S. Semiz, Cardiovascular Pharmacogenomics, “Pharmacogenomics – From Research to Clinic” Workshop for university lecturers, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. 2015.
M. Malenica, Čaušević, A., Silar, M., Dujic, T., Bego, T., Prnjavorac, B., and Semiz, S., DIAGNOSTIC RELEVANCE OF INFLAMMATORY MARKERS IN PREDIABETIC PATIENTS, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
M. Malenica, Čaušević, A., Silar, M., Dujic, T., Bego, T., Prnjavorac, B., and Semiz, S., DIAGNOSTIC RELEVANCE OF INFLAMMATORY MARKERS IN PREDIABETIC PATIENTS, in Clinical Chemistry and Laboratory Medicine, 53, S1, S646, 2015.
S. Semiz, Education in Bioethics, 2nd International Conference on Education, Culture and Identity (ICECI), International University of Sarajevo. 2015.
S. Semiz, Education in Bioethics, 2nd International Conference on Education, Culture and Identity (ICECI), International University of Sarajevo, Sarajevo, Bosnia and Herzegovina. 2015.
S. Semiz, Ethical issues in pharmacogenomics and personalized medicine, UNESCO Conference “BIOETHICS, MEDICAL ETHICS & HEALTH LAW”, Naples, Italy. 2015.
S. Mandal, Čaušević, A., Malenica, M., and Semiz, S., FREE FATTY ACIDS AND LIVER INFLAMMATION IN TYPE 2 DIABETIC WOMEN, in Clinical Chemistry and Laboratory Medicine, 53, S1, S647, 2015.
S. Mandal, Čaušević, A., Malenica, M., and Semiz, S., FREE FATTY ACIDS AND LIVER INFLAMMATION IN TYPE 2 DIABETIC WOMEN, IFCC-EFLM EuroMedLab Paris 2015 Congress, Paris, France. 2015.
T. Dujic, Čaušević, A., Bego, T., Malenica, M., Asimi, Z. Velija-, Pearson, E. R., and Semiz, S., The OCT1 reduced-function polymorphisms are associated with metformin-induced gastrointestinal side-effects,, in Diabetologia 58 (Suppl. 1.), s110, 2015; Presented at European Association for the Study of Diabetes- 51 EASD Annual Meeting, 2015.
S. Semiz, Pharmacogenomic Variations and Metformin Response, 3rd ESPT Conference “Integration of Pharmacogenomics in clinical decision support”, Budapest, Hungary. 2015.
S. Semiz, Pharmacogenomics and Personalized Treatment of Type 2 Diabetes, “Pharmacogenomics – From Research to Clinic” Workshop for university lecturers, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. 2015.
Z. Velija- Asimi, Semiz, S., and Dujic, T., Prediabetes incidence and risk of developing cardiovascular disease in women with polycystic ovary syndrome, Endocrine Abstracts, 38, P268. 2015.